Outcomes of second‐line axicabtagene ciloleucel for large B‐cell lymphoma in the UK

Andrea Kuhnl, Amy A. Kirkwood, Michael Northend, Caroline Besley, Ben Uttenthal, Jane Norman, Hwai Hiew, Frances Seymour, Bernard Maybury, Wendy Osborne, Francesca Sillito, Ahmed Abdulgawad, Ceri Jones, Pierre McCarthy, Aikaterini Panopoulou, John G. Gribben, Edward Bataillard, Nicolas Martinez‐Calle, Lavanya Gajendran, Maeve O'Reilly, Emil Kumar, Robert P. Wilson, Shenbagaram Kasivisvanathan, Nada Fadlelmula, Angharad Pryce, Olateni Awofisayo, Adrian Maraj, William Townsend, Kate Cwynarski, Shankara Paneesha, Amrith Mathew, Vaishali Dulobdas, Dima El‐Sharkawi, Thomas Creasey, Mary Warren, Ram Malladi, Mary Owen, Muddeha Waraich, Kushani Ediriwickrema, Joseph Froggatt, Alison Delaney, Andrew J. Davies, Rajesh Alajangi, Graham P. Collins, Robin Sanderson, Claire Roddie, Tobias Menne, Sridhar Chaganti

Open source

DOI: 10.1002/hem3.70312
Published: 2026-02
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70312,
  title = {Outcomes of second‐line axicabtagene ciloleucel for large B‐cell lymphoma in the UK},
  author = {Andrea Kuhnl and Amy A. Kirkwood and Michael Northend and Caroline Besley and Ben Uttenthal and Jane Norman and Hwai Hiew and Frances Seymour and Bernard Maybury and Wendy Osborne and Francesca Sillito and Ahmed Abdulgawad and Ceri Jones and Pierre McCarthy and Aikaterini Panopoulou and John G. Gribben and Edward Bataillard and Nicolas Martinez‐Calle and Lavanya Gajendran and Maeve O'Reilly and Emil Kumar and Robert P. Wilson and Shenbagaram Kasivisvanathan and Nada Fadlelmula and Angharad Pryce and Olateni Awofisayo and Adrian Maraj and William Townsend and Kate Cwynarski and Shankara Paneesha and Amrith Mathew and Vaishali Dulobdas and Dima El‐Sharkawi and Thomas Creasey and Mary Warren and Ram Malladi and Mary Owen and Muddeha Waraich and Kushani Ediriwickrema and Joseph Froggatt and Alison Delaney and Andrew J. Davies and Rajesh Alajangi and Graham P. Collins and Robin Sanderson and Claire Roddie and Tobias Menne and Sridhar Chaganti},
  year = {2026},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70312},
  url = {https://doi.org/10.1002/hem3.70312}
}

RIS

TY  - JOUR
TI  - Outcomes of second‐line axicabtagene ciloleucel for large B‐cell lymphoma in the UK
AU  - Andrea Kuhnl
AU  - Amy A. Kirkwood
AU  - Michael Northend
AU  - Caroline Besley
AU  - Ben Uttenthal
AU  - Jane Norman
AU  - Hwai Hiew
AU  - Frances Seymour
AU  - Bernard Maybury
AU  - Wendy Osborne
AU  - Francesca Sillito
AU  - Ahmed Abdulgawad
AU  - Ceri Jones
AU  - Pierre McCarthy
AU  - Aikaterini Panopoulou
AU  - John G. Gribben
AU  - Edward Bataillard
AU  - Nicolas Martinez‐Calle
AU  - Lavanya Gajendran
AU  - Maeve O'Reilly
AU  - Emil Kumar
AU  - Robert P. Wilson
AU  - Shenbagaram Kasivisvanathan
AU  - Nada Fadlelmula
AU  - Angharad Pryce
AU  - Olateni Awofisayo
AU  - Adrian Maraj
AU  - William Townsend
AU  - Kate Cwynarski
AU  - Shankara Paneesha
AU  - Amrith Mathew
AU  - Vaishali Dulobdas
AU  - Dima El‐Sharkawi
AU  - Thomas Creasey
AU  - Mary Warren
AU  - Ram Malladi
AU  - Mary Owen
AU  - Muddeha Waraich
AU  - Kushani Ediriwickrema
AU  - Joseph Froggatt
AU  - Alison Delaney
AU  - Andrew J. Davies
AU  - Rajesh Alajangi
AU  - Graham P. Collins
AU  - Robin Sanderson
AU  - Claire Roddie
AU  - Tobias Menne
AU  - Sridhar Chaganti
PY  - 2026
JO  - HemaSphere
DO  - 10.1002/hem3.70312
UR  - https://doi.org/10.1002/hem3.70312
ER  -

APA

Kuhnl, A., Kirkwood, A. A., Northend, M., Besley, C., Uttenthal, B., Norman, J., Hiew, H., Seymour, F., Maybury, B., Osborne, W., Sillito, F., Abdulgawad, A., Jones, C., McCarthy, P., Panopoulou, A., Gribben, J. G., Bataillard, E., Martinez‐Calle, N., Gajendran, L., O'Reilly, M., Kumar, E., Wilson, R. P., Kasivisvanathan, S., Fadlelmula, N., Pryce, A., Awofisayo, O., Maraj, A., Townsend, W., Cwynarski, K., Paneesha, S., Mathew, A., Dulobdas, V., El‐Sharkawi, D., Creasey, T., Warren, M., Malladi, R., Owen, M., Waraich, M., Ediriwickrema, K., Froggatt, J., Delaney, A., Davies, A. J., Alajangi, R., Collins, G. P., Sanderson, R., Roddie, C., Menne, T., & Chaganti, S. (2026). Outcomes of second‐line axicabtagene ciloleucel for large B‐cell lymphoma in the UK. HemaSphere. https://doi.org/10.1002/hem3.70312

Source records

crossref · retrieved 2026-09-27T03:33:52.808Z